Max Robotics — Global Service Robot Directory + US Certification

About

Dr. Satomi Yoshida is a leading researcher in urological oncology and perioperative medicine, with a specialized focus on optimizing surgical outcomes in robot-assisted radical prostatectomy. Her most cited work, "Effects of thienopyridine class antiplatelets on bleeding outcomes following robot-assisted radical prostatectomy" (2024, 7 citations), represents a critical contribution to the field by systematically evaluating the bleeding risks associated with thienopyridine-class antiplatelet agents—including ticlopidine, clopidogrel, and prasugrel—in patients undergoing this minimally invasive procedure. Through a rigorous cohort study leveraging a dedicated surgical database, Dr. Yoshida provided evidence-based insights that directly inform clinical decision-making for anticoagulation management in urological surgery. Her research addresses a pressing clinical challenge, balancing the need for thrombotic protection with the imperative to minimize hemorrhagic complications. While her citation count reflects the recent publication of this pivotal study, its immediate impact underscores its relevance to practicing urologists and surgical oncologists. Dr. Yoshida’s work exemplifies how targeted database-driven research can enhance patient safety and refine surgical protocols, establishing her as an emerging authority in the intersection of urological oncology and perioperative risk stratification.